Results 101 to 110 of about 67,800 (280)
Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation.
PLoS ONE, 2019 In the present study, we investigated the capabilities of a novel ultrasonic approach for real-time control of fibrinolysis under flow conditions. Ultrasonic monitoring was performed in a specially designed experimental in vitro system.
Dmitry A Ivlev +4 more
doaj +1 more source
Evaluation the best condition of Fibrinolytic protease production using factorial design by Streptomyces sp DPUA 1573 [PDF]
, 2012 XI Reunião Regional Nordeste da SBBq | 4th International Symposium in Biochemistry of Macromolecules and BiotechnologyFibrinolytic enzymes have the ability to degrade fibrin clots formed for avoiding intravascular thrombosis.
Clementino, E. L. +8 more
core
Advanced Healthcare Materials, Volume 14, Issue 11, April 25, 2025.A new dual‐layer hydrogel barrier for preventing postoperative abdominal adhesions is developed. The inner layer, consisting of polyethyleneimine (PEI) and thioctic acid (TA), enhanced adhesion to moist tissues. The outer layer combines zwitterionic, thermoresponsive hyaluronic acid with anti‐inflammatory epigallocatechin gallate (EGCG) and forms a ...
Mena Asha Krishnan +6 more
wiley +1 more source
BMC Biotechnology, 2012 Background Today, thrombosis is one of the most widely occurring diseases in modern life. Drugs with thrombolytic functions are the most effective methods in the treatment of thrombosis.
Yuan Jun +5 more
doaj +1 more source
Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. [PDF]
, 2009 PurposeDeposition of fibrin in the alveolar space is a hallmark of acute lung injury (ALI). Plasminogen activator inhibitor-1 (PAI-1) is an antifibrinolytic agent that is activated during inflammation. Increased plasma and pulmonary edema fluid levels of
Brady, Sandra +4 more
core +2 more sources
The never ending success story of tranexamic acid in acquired bleeding
Haematologica, 2020 Tranexamic acid (TXA) is an anti-fibrinolytic agent that acts by inhibiting plasminogen activation and fibrinolysis. Although its first clinical use dates back more than 50 years, this hemostatic agent is still the object of intense clinical and ...
Massimo Franchini +1 more
doaj +1 more source
Use of intrapleural recombinant streptokinase in a pregnant woman with pleural empyema
Archivo Médico de Camagüey, 2018 Background: pneumonia complicates 0,78-2,7 per 1 000 pregnancies placing the mother and the fetus at risk. Empyema as a complication of pneumonia in a pregnant patient adds a high rate of morbidity and mortality to the mother and the fetus if one does ...
Miguel Emilio García Rodríguez +5 more
doaj
Фармация и фармакология (Пятигорск), 2019 The search and development of direct and rapid anticoagulants used per os, is an urgent problem in physiological and medical science. A number of plants contain heparin-like components with a positive effect on the hemostatic system, both within normal ...
M. G. Lyapina +3 more
doaj +1 more source
A Novel Fibrinolytic Enzyme from Bacillus Sphaericus MTCC 3672: Optimization and Purification Studies [PDF]
, 2013 A novel extracellular fibrinolytic enzyme was produced from Bacillus sphaericus MTCC 3672 for dissolving blood clots. Optimized fermentation parameters achieved by one factor at a time approach had demonstrated 2.85 fold increase in fibrinolytic activity
Avhad, Devchand N. +2 more
core +1 more source
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases [PDF]
, 2018 © The Author(s) 2018. Cardiovascular disease (CVD) is the leading cause of death in the world and our approach to the control and management of CVD mortality is limited.
Chen, H +7 more
core +1 more source